Sarah Proehl, MD

Gilead Sciences, Inc.

Poster(s):

• P1644 - Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis Previously Treated With Fibrates or Obeticholic Acid
  Sunday, October 26, 2025

  3:30 PM - 7:00 PM PDT